Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 64.05%
March 31, 2026 63.41%
December 31, 2025 63.53%
September 30, 2025 62.38%
June 30, 2025 61.97%
March 31, 2025 63.13%
December 31, 2024 62.41%
September 30, 2024 63.39%
June 30, 2024 65.37%
March 31, 2024 62.97%
December 31, 2023 62.45%
September 30, 2023 54.29%
June 30, 2023 65.19%
March 31, 2023 65.28%
December 31, 2022 63.54%
September 30, 2022 64.79%
June 30, 2022 66.07%
March 31, 2022 66.96%
December 31, 2021 65.14%
September 30, 2021 67.55%
June 30, 2021 65.83%
March 31, 2021 66.19%
December 31, 2020 63.93%
September 30, 2020 65.55%
June 30, 2020 65.98%
Date Value
March 31, 2020 66.87%
December 31, 2019 63.47%
September 30, 2019 64.98%
June 30, 2019 66.08%
March 31, 2019 67.37%
December 31, 2018 52.54%
September 30, 2018 69.83%
June 30, 2018 68.80%
March 31, 2018 68.09%
December 31, 2017 68.63%
September 30, 2017 69.03%
June 30, 2017 68.50%
March 31, 2017 65.77%
December 31, 2016 69.25%
September 30, 2016 69.02%
June 30, 2016 69.58%
March 31, 2016 68.01%
December 31, 2015 64.05%
September 30, 2015 69.59%
June 30, 2015 69.46%
March 31, 2015 70.39%
December 31, 2014 67.23%
September 30, 2014 68.32%
June 30, 2014 69.18%
March 31, 2014 69.45%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Kao Corp. 39.51%
Kosé Holdings Corp. 69.91%
euglena Co., Ltd. 68.61%
Rohto Pharmaceutical Co., Ltd. 55.72%
Mandom Corp. 47.80%

Gross Profit Margin (Quarterly) Related Metrics